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Introduction {#sec1}
============

Lymph nodes (LNs) and other secondary lymphoid organs (SLOs) provide particular microenvironments for optimal induction and control of immune responses ([@bib22]; [@bib34]). These specialized niches are generated and maintained by different sets of vascular and mesenchymal stromal cells ([@bib38]; [@bib43]). The mesenchymal stromal cell network of the LN T cell zone is formed by fibroblastic reticular cells (FRCs) which are characterized by the expression of podoplanin (PDPN), and extracellular matrix proteins such as ERTR-7 and collagen-I ([@bib32]). Furthermore, FRCs regulate immune homeostasis and reactivity through the production of homeostatic chemokines, the immune-regulatory cytokine interleukin-7 (IL-7) ([@bib29]), and small molecules such as nitric oxide ([@bib31]; [@bib39]). However, although LN FRCs are phenotypically well-characterized ([@bib24]; [@bib32]), their development from mesenchymal precursors has remained elusive.

The differentiation of FRCs from their progenitor(s) is thought to be closely linked to lymphoid organogenesis. The early steps of both LN and Peyer's patch (PP) organogenesis involve the appearance of hematopoietic lymphoid tissue inducer (LTi) cells in the respective anlagen ([@bib33]; [@bib50]). Lymphotoxin-β receptor (LTβR) and receptor activator of NF-κB ligand (RANKL)-mediated interaction of LTi cells with mesenchymal stromal cells in the LN or PP anlage is thought to be critical for their further development ([@bib44]; [@bib38]). Indeed, mice lacking LTi cells fail to generate both LNs and PPs ([@bib15]; [@bib5]) and molecules of the tumor necrosis factor (TNF) family expressed by LTi cells provide essential signals for the developing SLOs ([@bib14]; [@bib26]; [@bib25]). LTβR engagement on stromal cells appears to be particularly important because the expression of IL-7, C-C motif chemokine 19 (CCL19), and CCL21 generates a positive feedback loop that attracts and activates further LTi cells ([@bib21]; [@bib35]). Mesenchymal stromal cells interacting with LTi cells during prenatal stages of SLO development are commonly referred to as lymphoid tissue organizer (LTo) cells and have been described as intercellular adhesion molecule 1 (ICAM-1)- and vascular cell adhesion molecule 1 (VCAM-1)-expressing cells that appear around embryonic day (E) 16 in the murine LN anlage ([@bib13]; [@bib47]). Gene-expression analysis revealed that these cells provide molecules involved in LN organogenesis including LTβR, RANKL, CCL19, CCL21, CXCL13, and IL-7 ([@bib13]; [@bib3]). However, neither global gene ablation of LTβR-ligands ([@bib14]; [@bib26]) or the LTβR itself ([@bib18]), nor LTβR expression on mesenchymal stromal cells of the LN anlage ([@bib13]; [@bib47]; [@bib3]) has allowed for the determination of the developmental window of LTβR-dependent mesenchymal LTo cell stimulation that is critical for LN or PP development.

Deletion of genes in a cell-specific and spatiotemporally controlled manner can be achieved by utilizing the Cre-*loxP* system. Here, we report the generation of a bacterial artificial chromosome (BAC)-transgenic mouse model that utilizes the *Ccl19* promoter to target the Cre recombinase specifically to mesenchymal stromal cells of the developing LN and to FRCs and FRC-like cells in adult LNs and PPs, respectively. Surprisingly, ablation of the LTβR on *Ccl19-cre* ^+^ mesenchymal stromal cells did not abrogate LN development. Moreover, although the maturation of LN FRCs from myofibroblastic precursors was blocked in *Ccl19-cre* × *Ltbr* ^fl/fl^ mice, the basic infrastructure of the adult LN with T and B cell zone segregation and a functional conduit system was established. However, *Ccl19-cre* × *Ltbr* ^fl/fl^ mice were immunodeficient because myofibroblastic FRC precursors were devoid of essential immune-stimulatory properties such as production of homeostatic chemokines and IL-7. Moreover, conditionally FRC-deficient animals showed an impaired resistance to viral infection, indicating that LTβR-mediated FRC maturation is critical for the maintenance of immunocompentence.

Results {#sec2}
=======

Genetic Targeting of LN FRCs {#sec2.1}
----------------------------

Currently, LN FRCs are defined as PDPN^+^CD31^−^ stromal cells in the T cell zone and interfollicular regions expressing smooth muscle actin (SMA) and the extracellular matrix protein ERTR7 ([@bib29]; [@bib32]). However, neither of these markers is truly FRC-specific. For example, PDPN is expressed on different stromal cell populations ([@bib32]) and hence *Pdpn-cre* transgenes target both PDPN^+^CD31^−^ FRCs and PDPN^+^CD31^+^ lymphatic endothelial cells (LECs) ([@bib36]). Here, we utilized the *Ccl19* promoter to direct Cre recombinase expression to LN FRCs. To silence the *Ccl21* gene, which is in close proximity to the *Ccl19* locus, the murine *Ccl21* gene was replaced by the human *CD8* gene in the BAC construct. Crossing of transgenic lines with *R26-eyfp* reporter mice ([@bib42]) facilitated screening for founders with exclusive transgene expression in nonhematopoietic cells ([Figure 1](#fig1){ref-type="fig"} A; see also [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B available online). Because two out of seven founder lines showed identical stromal cell-specific transgene expression, all further analyses were performed with founder line 1 designated as *Ccl19-cre*. Staining of CD45^−^ LN cells with antibodies against PDPN and CD31 revealed a normal LN stromal cell composition in *Ccl19-cre* × *R26-eyfp* mice ([Figure 1](#fig1){ref-type="fig"}B). Importantly, FRC specificity was high with 80%--90% of the EYFP signal being directed to the PDPN^+^CD31^−^ fraction ([Figures 1](#fig1){ref-type="fig"}C and 1D). In situ analysis using confocal laser scanning microscopy revealed that *Ccl19-cre* ^+^ cells were found mainly in the T cell zone and in interfollicular regions of the LN ([Figure 1](#fig1){ref-type="fig"}E). Three-dimensional (3D) reconstruction of high-resolution microscopic analyses showed that the transgene was expressed uniformly in the PDPN^+^ERTR7^+^ reticular T cell zone network ([Figure 1](#fig1){ref-type="fig"}F). Furthermore, FRCs ensheathing CD31^+^ high endothelial venules (HEVs) were transgene-positive ([Figure 1](#fig1){ref-type="fig"}G). *Ccl19-cre* ^+^ LN FRCs expressed CCL21 ([Figure 1](#fig1){ref-type="fig"}H, arrows) and CCL19 ([Figure 1](#fig1){ref-type="fig"}I, arrows) indicating that the *Ccl19-cre* transgene targets both past and present CCL19 expression in these nonhematopoietic cells.Figure 1*Ccl19-cre* Transgene Expression in LN Stromal Cells(A) LN cell suspensions from 6-week-old *Ccl19-cre* × *R26-eyfp* mice were depleted of CD45^+^ cells, and EYFP expression was determined by flow cytometry.(B) Representative dot plot analysis with quadstat values of CD31 and PDPN expression in CD45^−^ inguinal LN stromal cells.(C) Dot plot analysis including quadstat values of CD31 and PDPN expression in CD45^−^EYFP^+^ LN stromal cells.(D) EYFP expression in CD45^−^ LN stromal cell populations (PDPN^+^CD31^−^ fibroblastic reticular cells \[FRC\]; PDPN^−^CD31^−^ double-negative \[DN\] cells; PDPN^+^CD31^+^ lymphatic endothelial cells \[LECs\]; PDPN^−^CD31^+^ blood endothelial cells \[BEC\]). Inguinal LNs from individual mice were pooled, mean values ± SEM from 15 mice analyzed in three independent experiments.(E) Confocal microscopic analysis of an *Ccl19-cre* × *R26-eyfp* inguinal LN section by using antibodies against the indicated markers, merged channels in left panel; scale bar represents 200 μm.(F) 3D reconstruction of T cell zone FRC network, merged channels in left panel, scale bar = 10 μm.(G) EYFP expression in perivascular FRCs (arrow); scale bar represents 20 μm.(H and I) Expression of the homeostatic chemokines CCL21 (H, arrows) and CCL19 (I, arrows) in EYFP^+^ FRCs in T cell zones of *Ccl19-cre* × *R26-eyfp* inguinal LNs; scale bar represents 20 μm. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Stromal cell composition in spleen is different from LNs because the double-negative (DN, PDPN^−^CD31^−^) fraction is dominant and PDPN^+^CD31^+^ LECs are not present in this organ ([@bib36]). *Ccl19-cre* transgene activity was highest in the DN cell population ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D) with EYFP^+^ cells being dispersed in all compartments of the white pulp ([Figure S1](#mmc1){ref-type="supplementary-material"}E). High densities of transgene-positive cells could be detected in the area of the marginal zone ([Figure S1](#mmc1){ref-type="supplementary-material"}F) and around central arterioles ([Figure S1](#mmc1){ref-type="supplementary-material"}G). In contrast, transgene activity in PP stromal cells was high in PDPN^+^CD31^−^ cells and moderate in DN cells with around 80% and 20% of all EYFP^+^ cells, respectively ([Figures S1](#mmc1){ref-type="supplementary-material"}H and S1I). Because PDPN^+^CD31^−^ cells in PPs are still undefined, we have referred to them as FRC-like cells. Transgene-positive cells were rare in subdomal areas and more dense in the abluminal part of the PP ([Figure S1](#mmc1){ref-type="supplementary-material"}J), but associated both with T cell- and B cell-rich areas ([Figure S1](#mmc1){ref-type="supplementary-material"}K), suggesting that PP FRC-like cells are involved in the orchestration of both T and B cell responses. Taken together, the *Ccl19-cre* transgene permits in vivo targeting of LN FRCs and FRC-like cells of PPs.

LN Formation Is Independent of LTβR-Signaling in *Ccl19-Cre*^+^ Mesenchymal Stromal Cells {#sec2.2}
-----------------------------------------------------------------------------------------

To assess *Ccl19-Cre* transgene activity during early LN development, we determined reporter gene expression in inguinal LN anlagen of *Ccl19-cre* × *R26-eyfp* on E16.5 and E18.5. We found that *Ccl19-cre* ^+^ stromal cells were highly abundant in the E16.5 inguinal LN anlage ([Figures 2](#fig2){ref-type="fig"} A; [Figure S2](#mmc1){ref-type="supplementary-material"}A). Furthermore, the E16.5 inguinal LN anlage had attracted CD4^+^ LTi cells, which most likely deliver the necessary LTα~1~β~2~ for stimulation of the LTβR on mesenchymal stromal organizer cells. The number of *Ccl19-cre* ^+^ stromal cells grew approximately 3-fold until E18.5, whereas the CD4^+^ LTi cell population expanded only modestly ([Figure 2](#fig2){ref-type="fig"}B; [Figure S2](#mmc1){ref-type="supplementary-material"}B). To assess whether Cre-recombinase expression reflected the kinetics of *Ccl19* expression in developing LNs, we determined both Cre-recombinase and *Ccl19* mRNA production in neonatal and week 2 and six LN homogenates by quantitative RT-PCR (qRT-PCR). Endogenous *Ccl19* expression ([Figure 2](#fig2){ref-type="fig"}C) correlated well with Cre expression ([Figure 2](#fig2){ref-type="fig"}D) driven by the *Ccl19* promoter on the BAC transgene. In contrast, *Ltbr* expression fluctuated with the highest expression being measureable in the neonatal LN ([Figure 2](#fig2){ref-type="fig"}E). Confocal microscopic analysis revealed that *Ccl19-cre* transgene expression was highly abundant in neonatal inguinal LNs ([Figure 2](#fig2){ref-type="fig"}F, left panels). 3D reconstruction of high-resolution analyses indicated that *Ccl19-cre*-expressing stromal cells in the developing LN had formed a dense network ([Figure 2](#fig2){ref-type="fig"}F, right panels) reminiscent of the FRC network in the adult LN. Whereas *Ccl19-cre* ^+^ stromal cells expressed low amounts of PDPN, the mesenchymal markers smooth muscle actin (SMA) and platelet-derived growth factor receptor-β (PDGFRβ) were highly expressed ([Figure 2](#fig2){ref-type="fig"}G), indicating that the *Ccl19-cre* transgene targets mesenchymal stromal cells in developing LNs.Figure 2Characterization of *Ccl19-cre*^+^ Mesenchymal Stromal Cells in Developing LNs(A--E) *Ccl19-cre* × *R26-eyfp* embryos were analyzed for transgene expressing cells in inguinal LN anlagen by confocal microscopy at embryonic days E16.5 (A) and E18.5 (B) by using the indicated stainings. Left panels show merge of all channels; scale bars represent 100 μm. Inguinal LNs from neonatal, 2- and 6-week-old *Ccl19-cre* mice were analyzed by quantitative RT-PCR for the expression of *Ccl19* (C), Cre recombinase (D), and *Ltbr* (E). Values indicate mean ± SEM from two individual LNs from three mice analyzed in two independent experiments.(F) Confocal microscopic analysis with single and combined stainings for the indicated markers of neonatal inguinal LNs from *Ccl19-cre* × *R26-eyfp* mice (confocal plane in left panels). Maximum intensity projection (3D) from z stack (upper right panel) and magnified 3D rendering of fibroblastic network (lower right panel, represents boxed area in upper panel); scale bars represent 100 μm.(G) Expression of the smooth muscle actin (SMA) and platelet-derived growth factor receptor-β (PDGFRβ) in neonatal inguinal LNs from *Ccl19-cre* × *R26-eyfp* mice; scale bar represents 10 μm.(H) Neonatal inguinal LNs from conditionally LTβR-deficient *Ccl19-cre* × *R26-eyfp* mice analyzed by confocal microscopy (confocal plane in left panels) with maximum intensity projection (3D) from z stack (upper right panel) and magnified 3D rendering of fibroblastic network (lower right panel, represents boxed area in upper panel); scale bars represent 100 μm.(I) Expression of SMA and PDGFRβ in conditionally LTβR-deficient neonatal inguinal LNs; scale bar represents 10 μm. Representative data from one out of three independent experiments. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

The differentiation of adult stromal cell subpopulations is thought to depend on LTβR signaling ([@bib38]; [@bib44]). Because lymphocytes are rare in neonatal LNs and LTβR-dependent stimulation of mesenchymal stromal cells is mainly provided by LTi cells ([@bib12]; [@bib47]), it is most likely that *Ccl19-cre* ^+^ mesenchymal stromal cell in neonatal LNs received LTβR signals from LTi cells. Interestingly, deletion of the LTβR on *Ccl19-cre* ^+^ mesenchymal stromal cells did not abrogate LN formation ([Figure 2](#fig2){ref-type="fig"}H). Furthermore, formation of a stromal cell network in neonatal LNs was not affected by mesenchymal stromal cell-specific LTβR-ablation ([Figure 2](#fig2){ref-type="fig"}H, right panels). Likewise, expression of SMA and PDGFRβ ([Figure 2](#fig2){ref-type="fig"}I) was not altered by the selective LTβR-ablation. Gross pathological examination of adult *Ccl19-cre* × *Ltbr* ^fl/fl^ mice (4--6 weeks) after injection of Evan's Blue revealed that all LNs were present (data not shown). In contrast, *Ccl19-cre*-dependent ablation of the LTβR in PPs led to significantly reduced PP numbers ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Taken together, these data indicate that *Ccl19-cre* expression in PP mesenchymal stromal cells occurs in a developmental window of critical LTβR-sensitivity. Conversely, *Ccl19-cre*-expressing mesenchymal stromal cells in developing LNs do not require LTβR signals to facilitate LN formation.

LN Structure and Organization in the Absence of FRC-Specific LTβR Signaling {#sec2.3}
---------------------------------------------------------------------------

To assess the impact of *Ccl19-cre*-mediated LTβR-ablation on global LN structure and organization, we utilized recently developed optical projection tomography (OPT) routines ([@bib28]). The mesoscopic imaging analysis revealed that LNs of *Ccl19-cre* × *Ltbr* ^fl/fl^ mice had developed clearly distinguishable B cell follicles and a HEV network ([Figure 3](#fig3){ref-type="fig"}A). Quantification of the 3D data showed that conditionally LTβR-deficient LNs were approximately 25%--30% smaller than control LNs ([Figure 3](#fig3){ref-type="fig"}B) and exhibited a comparable reduction in B cell follicle size ([Figure 3](#fig3){ref-type="fig"}C), HEV length ([Figure 3](#fig3){ref-type="fig"}D), and complexity of the HEV network ([Figure 3](#fig3){ref-type="fig"}E). The OPT-based finding that LNs with FRC-specific LTβR-deficiency were still able to establish the basic LN infrastructure was supported by confocal microscopy, which showed that LNs had generated clearly distinguishable T and B cell zones ([Figure 3](#fig3){ref-type="fig"}F). The global reduction of LN size without specific impairment of substructures was reflected by the comparable reduction of various hematopoietic cell populations ([Figure 3](#fig3){ref-type="fig"}G). Thus, FRC-specific ablation of LTβR-signaling did not affect the formation of the basic LN structure with clear T and B cell zone segregation.Figure 3Impact of FRC-Specific LTβR Signaling on Peripheral LN Structure(A) Inguinal LNs from 4-week-old *Ccl19-cre* × *Ltbr*^fl/fl^ and *Ltbr*^+/+^ controls were analyzed by OPT for the presence of the HEV network (MECA-79^+^) and B cell follicles (B220^+^); scale bar represents 500 μm. Quantitative analysis based on OPT data for (B) LN volume, (C) B cell follicle volume, (D) HEV network length, and (E) HEV branching points (mean ± SEM, n = 6 mice pooled from two independent experiments).(F) Confocal microscopic analysis of inguinal LNs from 4-week-old *Ccl19-cre* × *Ltbr*^fl/fl^ and *Ltbr*^+/+^ controls by using antibodies against T cells (CD4) and B cells (B220); scale bar represents 200 μm.(G) Flow cytometry-based quantification of LN cellularity. Values indicate relative cell numbers in *Ccl19-cre* × *Ltbr*^fl/fl^ mice compared to *Ltbr*^+/+^ mice (CD4, CD4^+^ T cells; CD8, CD8^+^ T cells; BC, B cells; DC, dendritic cells; MP, macrophages; mean ± SEM, n = 6 mice from two independent experiments).

To assess whether the conditional LTβR-deficiency affects LN stromal cell composition, we prepared single-cell suspensions from *Ccl19-cre* × *Ltbr* ^fl/fl^ and control *Ltbr* ^+/+^ LNs, depleted CD45^+^ hematopoietic cells and stained the enriched stromal cells with antibodies against PDPN and CD31. Flow cytometric analysis revealed a loss of PDPN^+^CD31^−^ cells that coincided with a significant increase of PDPN^−^CD31^−^ cells ([Figure 4](#fig4){ref-type="fig"} A). Importantly, the remaining PDPN^+^CD31^−^ cells had lost LTβR expression ([Figures 4](#fig4){ref-type="fig"}B and 4C). Confocal microscopic analysis confirmed the substantial reduction of PDPN expression in *Ccl19-cre* × *Ltbr* ^fl/fl^ LNs ([Figure 4](#fig4){ref-type="fig"}D). However, ERTR7 protein production and the formation of the fibroblastic reticular network was not affected by FRC-specific LTβR ablation ([Figure 4](#fig4){ref-type="fig"}D). Moreover, the fibroblastic network still generated ERTR7-ensheathed collagen bundles ([Figure 4](#fig4){ref-type="fig"}E), i.e., the conduit system, which rapidly drained small molecules through the T cell zone, both in the presence and absence of LTβR on T cell zone reticular cells ([Figure 4](#fig4){ref-type="fig"}F). T cell zone reticular cells both in the LN parenchyma and surrounding HEVs had lost CCL21 positivity in *Ccl19-cre* × *Ltbr* ^fl/fl^ LNs, whereas vascular endothelial cells in HEVs still produced this chemokine ([Figure 4](#fig4){ref-type="fig"}G). Quantitative RT-PCR analysis of whole LN homogenates confirmed the substantial loss of *Ccl21* mRNA expression in conditionally LTβR-deficient LNs ([Figure 4](#fig4){ref-type="fig"}H). Moreover, *Ccl19-cre* × *Ltbr* ^fl/fl^ LNs produced significantly less *Ccl19* ([Figure 4](#fig4){ref-type="fig"}I) and *Il7* ([Figure 4](#fig4){ref-type="fig"}J) mRNA but almost normal amounts of the B cell zone chemokine *Cxcl13* ([Figure 4](#fig4){ref-type="fig"}K). Taken together, these data show that *Ccl19* promoter-dependent LTβR-ablation profoundly altered the LN stromal cell composition and abolished expression of molecules in T cell zone reticular cells, which are considered part of the molecular signature of FRCs.Figure 4FRC-Specific LTβR Ablation Alters LN Stromal Cell Composition and Phenotype(A) Frequency of the major stromal cell populations (PDPN^−^CD31^−^ DN cells, PDPN^+^CD31^−^ \[FRC\], PDPN^+^CD31^+^ \[LEC\]; PDPN^−^CD31^+^ \[BEC\]) in inguinal LNs from *Ccl19-cre* × *Ltbr*^fl/fl^ and *Ltbr*^+/+^ mice as determined by flow cytometry; values represent mean ± SEM (n = 9 mice from three independent experiments).(B) Representative LTβR expression patterns on PDPN^+^CD31^−^ (FRC) stromal cells of *Ccl19-cre* × *Ltbr*^fl/fl^ (red) and *Ltbr*^+/+^ (black) mice determined by flow cytometry; staining with isotype control antibody in gray.(C) Summary of LTβR expression displayed as mean fluorescent intensity (MFI), mean ± SEM (n = 4 mice from two independent experiments).(D--G) Confocal microscopic analysis of inguinal LN stromal cells from 6-week-old *Ccl19-cre* × *Ltbr*^fl/fl^ and *Ltbr*^+/+^ controls. (D) T cell zone reticular network revealed by ERTR-7 and PDPN staining, merged channels in left panel; scale bar represents 20 μm. (E) High-resolution analysis of T cell zone conduit with collagen-1 bundles ensheathed by ERTR-7; scale bar represents 2 μm. (F) Drainage of 40 kDa FITC dextran through LN conduits 2 min after subcutaneous injection. Left panel shows magnified FITC staining in T cell zone; scale bar represents 100/40 μm. (G) Vascular (HEV, high endothelial venule) and T cell zone stromal cell-associated CCL21 expression, merged channels in left panel, CD31 and CCL21 merge in right panel; scale bar represents 20 μm.(H--K) Inguinal LNs from 6-week-old *Ccl19-cre* × *Ltbr*^fl/fl^ and *Ltbr*^+/+^ controls were analyzed by quantitative RT-PCR for the expression of *Ccl21* (H), *Ccl19* (I), *Il7* (J), and *Cxcl13* (K). Values indicate mean ± SEM from two individual LNs from three mice analyzed in two independent experiments.

LTβR Promotes FRC Differentiation from Myofibroblastic Precursors {#sec2.4}
-----------------------------------------------------------------

The pronounced reduction of PDPN^+^ FRCs and the concomitant increase in DN stromal cells in LNs *Ccl19-cre* × *Ltbr* ^fl/fl^ suggested that DN LN stromal cells may differentiate into FRCs. Indeed, in vitro culture of sorted DN cells from *Ccl19-cre × R26-eyfp* LNs in the presence of LTi cells resulted in activation of the *Ccl19* promoter ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). Moreover, upregulation of EYFP was accompanied by a pronounced increase in PDPN expression ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Crossing of *Ccl19-cre* × *Ltbr* ^fl/fl^ mice with *R26-eyfp* reporter mice confirmed that genetically labeled (i.e., EYFP^+^) FRCs emerge from DN precursors in a LTβR gene dose-dependent fashion ([Figures 5](#fig5){ref-type="fig"}A and 5B). LTβR-dependent FRC maturation was associated not only with the upregulation of PDPN ([Figure 5](#fig5){ref-type="fig"}A) but also with a substantial increase in ICAM-1 and VCAM-1 expression ([Figure 5](#fig5){ref-type="fig"}C). Likewise, EYFP^+^PDPN^lo^ cells from *Ccl19-cre* × *R26-eyfp* LNs expressed moderate amounts of ICAM-1 and VCAM-1 ([Figure S3](#mmc1){ref-type="supplementary-material"}E). To further characterize the phenotypical changes associated with LTβR-dependent FRC differentiation, we first determined the expression of myofibroblast and pericyte markers in LN stromal cell preparations. As shown in [Figure 5](#fig5){ref-type="fig"}D, abortion of FRC maturation was associated with increased *Acta2*, *Cnn1*, and *Pdgfrb* mRNA expression, whereas *Pdgfra* and *Cspg4* mRNA expression was not affected. Confocal microscopy confirmed upregulation of SMA in myofibroblastic FRC precursors surrounding HEVs ([Figure 5](#fig5){ref-type="fig"}E) and in the T cell zone network ([Figure 5](#fig5){ref-type="fig"}F, arrowheads). Likewise, PDGFRβ was upregulated in FRC precursors in both locations ([Figure 5](#fig5){ref-type="fig"}G), whereas perivascularly expressed calponin-1 was specifically upregulated in myofibroblastic cells in the T cell zone network ([Figure 5](#fig5){ref-type="fig"}H). In contrast, the expression of the pericyte marker NG2 around small blood vessels was not affected by the selective LTβR-deficiency ([Figure 5](#fig5){ref-type="fig"}I). Thus, myofibroblastic FRC precursors require LTβR stimulation to acquire the characteristic mature phenotype with the expression of homeostatic and immune-regulatory molecules.Figure 5LTβR-Dependent FRC Maturation(A) LN stromal cells from 6-week-old *Ccl19-cre* × *R26-eyfp* mice with wild-type (^+/+^, WT) and heterozygously (^+/fl^) or homozygously floxed (^fl/fl^) *Ltbr* loci were assessed by flow cytometry for EYFP expression by using back gating. Representative dot plot analysis with quadstat values of CD31 and PDPN expression is shown.(B) EYFP expression in FRCs and DN cells in the indicated *Ltbr* genotype of *Ccl19-cre* × *R26-eyfp* mice; mean ± SEM (n = 3 mice from two independent experiments).(C) Representative analysis of ICAM-1 and VCAM-1 expression on *Ltbr*^+/+^ DN cells from *Ccl19-cre* × *R26-eyfp* mice (black), EYFP^+^*Ltbr*^+/+^ FRCs of *Ccl19-cre* × *R26-eyfp* mice (red), and EYFP^+^ cells of *Ccl19-cre* × *R26-eyfp*x*Ltbr*^fl/fl^ mice (blue).(D) Inguinal LNs from 6-week-old *Ccl19-cre* × *Ltbr*^fl/fl^ and *Ltbr*^+/+^ controls were analyzed by quantitative RT-PCR for the expression of *Acta2* (SMA), *Cnn1* (Calponin-1), *Pdgfrb*, *Pdgfra*, and *Cspg4* (NG2). Values indicate mean ± SEM from two individual LNs from \>3 mice analyzed in two independent experiments.(E--I) Confocal microscopic analysis of inguinal LN stromal cells from 6-week-old *Ccl19-cre* × *R26-eyfp*x*Ltbr*^fl/fl^ mice and *Ltbr*^+/+^*Ccl19-cre* × *R26-eyfp* controls. Reconstruction of perivascular (E) and T cell zonal (F) stromal cell network by analyzing CD31, SMA, and EYFP expression is shown. Arrowheads indicate perivascular EYFP expression, arrows indicate SMA^+^EYFP^+^ cells in orthogonal sections, and scale bars represent 10 μm.(G) Analysis of perivascular and T cell zonal expression of EYFP and PDGFRβ; scale bar represents 20 μm, all panels show merged channels. Reconstruction of perivascular and network-forming cells expressing CNN1 (H) and NG2 (I) and EYFP, merged channels in left panels; scale bars represent 30 μm; representative data out of three independent experiments. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

FRC Maturation Guarantees Immunocompetence during Viral Infection {#sec2.5}
-----------------------------------------------------------------

To determine the functional consequences of FRC-specific LTβR-deficiency on intranodal T cell migration, we utilized intravital 2-photon microscopy. Adoptive transfer of C57BL/6 T cells into *Ccl19-cre* × *Ltbr* ^fl/fl^ mice or control mice revealed a significant reduction of T cell speed in the T cell zone parenchyma under conditions of selective LTβR-ablation, with an average speed close to *Ccr7* ^*−/−*^ T cells ([Figure 6](#fig6){ref-type="fig"} A). In contrast, T cell speed around HEVs was not affected by the absence of mature FRCs ([Figure 6](#fig6){ref-type="fig"}A). Because T cell motility within the T cell zone parenchyma is partially dependent on CCR7-mediated signals ([@bib49]; [Figure 6](#fig6){ref-type="fig"}A), we assessed whether LTβR-dependent FRC maturation with upregulation of CCR7 ligands impacts on dendritic cell (DC)-CD8^+^ T cell interaction. To this end, mouse hepatitis virus (MHV)-specific CD8^+^ T cells expressing a T cell receptor recognizing the H2-K^b^-binding S598 epitope were adoptively transferred into *Ccl19-cre* × *Ltbr* ^fl/fl^ or LTβR-competent control mice. Subsequent subcutaneous injection of S598-pulsed DCs revealed that the conditional LTβR ablation did not lead to a reduction of DC-mediated T cell activation ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Next, we assessed whether the conditional LTβR-deficiency affects global immune responsiveness in *Ccl19-cre* × *Ltbr* ^fl/fl^ mice by using systemic infection with the lymphocytic choriomeningitis virus (LCMV) WE strain, which is controlled in a CD8^+^ T cell and perforin-dependent manner ([@bib23]). Conditionally LTβR-deficient mice failed to reduce viral titers in LNs and to clear the virus from peripheral organs such as the kidney by day 8 postinfection ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Furthermore, *Ccl19-cre* × *Ltbr* ^fl/fl^ mice showed significantly reduced antiviral T cell responses in LNs ([Figure S4](#mmc1){ref-type="supplementary-material"}D), indicating a globally reduced capacity to cope with viral infections when LN FRCs fail to generate an immune-stimulatory environment. However, under conditions of systemic LCMV distribution, other factors than deficient LN FRC maturation, such as the lack of PPs, could have contributed to the observed immunodeficiency in *Ccl19-cre* × *Ltbr* ^fl/fl^ mice. Therefore, we resorted to an infection system with exclusive replication in a tissue-draining LN. Following intranasal application, the murine coronavirus MHV establishes an infection in the central nervous system (CNS) during which systemic spread is prevented by swift induction of antiviral immune responses in the cervical LN ([@bib7]; [@bib19]). Successful control of the acute MHV infection depends on type I interferon (IFN)-producing plasmacytoid dendritic cells ([@bib9]) and both CD8^+^ and CD4^+^ T cells ([@bib4]). To assess the impact of the relative deficiency of CCR7 ligands in LN stromal cells of *Ccl19-cre* × *Ltbr* ^fl/fl^ mice, we compared conditionally LTβR-deficient mice with *plt/plt* mice, which lack the expression of CCR7 ligands specifically in secondary lymphoid organs ([@bib20]). We found that mice with FRC-specific LTβR deficiency showed a more dramatic weight loss compared to *plt/plt* mice ([Figure 6](#fig6){ref-type="fig"}B) and exhibited higher viral titers in the CNS at day 10 postinfection ([Figure 6](#fig6){ref-type="fig"}C). The failure of both *Ccl19-cre* × *Ltbr* ^fl/fl^ and *plt/plt* mice to clear the virus from the CNS and hence to prevent weight loss is most likely due to the strongly impaired antiviral T cell response in this vulnerable organ ([Figure 6](#fig6){ref-type="fig"}D). Interestingly, recruitment of fully activated IFN-γ-secreting effector T cells ([Figures 6](#fig6){ref-type="fig"}E and 6F) was reduced in *Ccl19-cre* × *Ltbr* ^fl/fl^ compared to *plt/plt* mice indicating that the impaired antiviral immunity in *Ccl19-cre* × *Ltbr* ^fl/fl^ mice can only be partially explained by the lack of CCL19 and CCL21 within the CNS-draining LN. Taken together, these data indicate that LTβR-mediated maturation of LN FRCs is critical for the generation of protective antiviral T cell responses.Figure 6T Cell Function in the Absence of FRC-Specific LTβR Signaling(A) Motility of T cells from C57BL/6N (WT) or CCR7-deficient donors in the T cell zone and around HEVs in popliteal LNs of *Ccl19-cre* × *Ltbr*^fl/fl^ (closed symbols) and *Ltbr*^+/+^ (open symbols) mice as determined by intravital two-photon microscopy. Values represent single tracks pooled from two independent experiments (n = 4 mice, mean indicated by horizontal bar).(B--D) *Ccl19-cre* × *Ltbr*^fl/fl^, *Ltbr*^+/+^, and *plt/plt* mice were infected intranasally with 5 × 10^4^ pfu of MHV A59. (B) Weight loss was recorded during the indicated time period following infection. Values indicate mean percentage of the initial weight ± SEM (n = 8 mice per group, one-way ANOVA with Tukey\'s post test). (C) Viral titers in brain homogenates were determined at day 10 postinfection. Data represent mean viral titers ± SEM, pooled data from two independent experiments (n = 8 mice); nd, not detectable. (D) T cell responses were determined by tetramer analysis of CNS-infiltrating S598-specific CD8^+^ T cells (left panel) and intracellular staining for S598-responsive IFN-γ-producing CD8^+^ T cells (middle panel), and M133-responsive IFN-γ-producing CD4^+^ T cells (right panel) on day 10 post infection. Values indicate mean percentages ± SEM of specific cells in the respective CD8^+^ or CD4^+^ T cell population (n = 8 mice per group). See also [Figure S4](#mmc1){ref-type="supplementary-material"}.(D--F) T cell responses were determined by tetramer analysis of CNS-infiltrating S598-specific CD8^+^ T cells (D) and intracellular staining for S598-responsive IFN-γ-producing CD8^+^ T cells (E), and M133-responsive IFN-γ-producing CD4^+^ T cells (F) on day 10 postinfection. Values indicate mean percentages ±SEM of specific cells in the respective CD8^+^ or CD4^+^ T cell population (n = 8 mice per group).

Discussion {#sec3}
==========

The assembly of hematopoietic LTi cells and mesenchymal stromal cells in the LN anlage and their positive feedback-type interaction is one of the first critical steps in LN formation. Whereas the molecular details involved in LTi cell-dependent stimulation of LN development have been thoroughly described (reviewed in [@bib38]; [@bib44]), the characterization of the stromal side of the LTi-mesenchymal LTo cell interaction has suffered from the lack of suitable tools to dissect ontogeny and function of these cells. We have addressed this need and describe in this study a model based on cell-specific expression of the Cre-recombinase that facilitates the dissection of mesenchymal stromal cell development during LN formation and the definition of critical molecular interactions between mesenchymal stromal and hematopoietic cells.

Mesenchymal precursors in the LN anlage express PDPN, but are ICAM-1- and VCAM-1-negative ([@bib11]; [@bib47]; [@bib3]). These precursors develop into the mesenchymal LTo cell defined by intermediate to high ICAM-1 and VCAM-1 expression and the concomitant upregulation of essential molecules involved in LN organogenesis, including CCL19 ([@bib3]) Notably, LTβR and the tumor necrosis factor receptor 1 (TNFR1) are highly expressed on both the mesenchymal precursor and the mesenchymal LTo cell ([@bib3]) whereby LTβR signaling in the mesenchymal precursor is critical for the transition to the ICAM-1^+^VCAM-1^+^ mesenchymal LTo cells ([@bib47]). However, ablation of LTβR signaling in mesenchymal stromal cells in the developing LN, i.e., ICAM-1^+^VCAM-1^+^ stromal cells expressing CCL19 in our model, did not prohibit the formation of LNs and the transition of the mesenchymal stromal cells of the prenatal LN into myofibroblastic FRC precursors (pre-FRCs) in postnatal LNs. Importantly, progression toward the immune-stimulatory, mature FRC was strictly dependent on LTβR signaling. Thus, our data together with previous studies ([@bib47]; [@bib3]) indicate that LN mesenchymal stromal cell development is characterized by two distinct developmental windows of critical LTβR signaling, i.e., initially during the transition of the mesenchymal precursor to the mesenchymal LTo cells and as a final maturation stimulus for T cell zone FRCs.

Development of PPs starts with recruitment of hematopoietic LTi cells and CD11c-expressing lymphoid tissue initiator cells ([@bib50]; [@bib46]), which both serve as sources of LTβR ligands. Again, LTβR-mediated stimulation of mesenchymal LTo cells triggers production of homeostatic cytokines and IL-7, which are essential for PP development ([@bib1]; [@bib16]). The results of our study indicate that CCL19 expression in developing PP mesenchymal stromal cells occurs during a critical phase of LTβR sensitivity. In contrast, LTβR signaling in *Ccl19-Cre* ^*+*^ mesenchymal stromal cells in LN anlagen was not mandatory for LN development. However, the presence of the LTβR on endothelial cells appears to be essential during early stages of LN formation ([@bib37]). Future studies utilizing the *Ccl19-Cre* model and other stromal cell-specific Cre-driver mice will provide a comprehensive characterization of the critical LTβR-sensitive stage during LTo development in LNs and PPs.

Several functions have been assigned to FRCs in adult LNs, such as the generation of the conduit system to facilitate rapid transfer of small antigens through the T cell zone ([@bib40]), regulation of the LN vasculature ([@bib10]), coordination of T cell and dendritic cell interaction ([@bib2]), maintenance of T cell homeostasis via IL-7 ([@bib29]), and tolerization of self-reactive T cells ([@bib17]). Our analysis indicates that the basic infrastructure of the LN including the conduit system and the HEV network is generated by myofibroblastic FRC-precursors in an LTβR-independent fashion. It remains to be determined whether other receptors involved in lymphoid organogenesis such as RANKL or TNFR1 compensate for the lack of LTβR. Clearly, LTβR-signaling was necessary for the maturation of FRCs from PDPN-negative myofibroblastic precursors and the optimal support of antiviral immunity provided by the adaptive immune system. Following exposure to inflammatory stimuli, FRCs respond with an activation program that leads to upregulation of molecules involved in innate and adaptive immune responses ([@bib45]; [@bib32]). Hence, it is likely the LTβR-mediated stimulation of pre-FRCs serves as a critical switch for global immune responsiveness by unleashing the full immune-stimulatory capacity of the mature FRC.

In conclusion, our study provides further evidence for a common theme in mesenchymal stromal cell differentiation, namely the LTβR-dependent conversion of a sessile myofibroblast into an immunologically highly active stromal cell. Such profound LTβR-mediated transformation into FRC-like cells has been described for vascular smooth-muscle cells during the formation of organized lymphoid follicles surrounding heavily atherosclerotic aortas ([@bib30]). Likewise, follicular dendritic cells (FDCs) that develop in ectopic lymphoid tissues can descend from PDGFRβ-expressing perivascular precursors ([@bib27]). Interestingly, only the final maturation of FDCs into immunologically active cells was dependent on lymphotoxin-mediated signals. Whereas FDCs in ectopic lymphoid tissues can emerge from ubiquitous perivascular precursors ([@bib27]), mature LN FRCs originate from PDPN-negative myofibroblastic progenitors that can form the global stromal cell network of the developing LN and that are distributed throughout the T cell zone and interfollicular regions of the adult LN. Despite the remaining unknowns concerning the differentiation of mesenchymal stromal cells of secondary and tertiary lymphoid organs, the results of this study suggest that timing of LTβR targeting for the attenuation of exaggerated immune responses may be critical ([@bib6]), i.e., mesenchymal stromal cell differentiation should be blocked before the stage of the immunologically fully active FRC---or FDC---has been reached.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

BAC-transgenic C57BL/6N-*Tg(Ccl19-Cre)* ^*489Biat*^ (*Ccl19-Cre*) mice were generated as described previously ([@bib36]). The coding sequence for the Cre-recombinase and a truncated form of the human *CD4* gene, separated by an IRES sequence and including a stop codon, was inserted into *Ccl19* exon 1 utilizing the endogenous ATG translation start codon on the 180 kb BAC RP23 446D10 (Invitrogen). Because the *Ccl21b* gene is in close proximity to *Ccl19*, the C*cl21b* gene was deleted on the BAC by inserting the human *CD8* gene into the first exon of the *Ccl21b* locus. The BAC carried at least 90 kb of sequence upstream of the *Ccl19* transcription start site. Integration of the Cre-recombinase was confirmed by Southern blot analysis. Modified BACs were screened with 5′ATG PCR (forward 5′-GCACACGAATGTGGATGTTC-3′, reverse 5′-CTGCACACAGACAGGAGCAT-3′) and 3′polyA PCR (forward 5′-ATGTGGCAGTGTCTGCTGAG-3′, reverse 5′-CCTGTAGCCAGAGGTTGGAG-3′). Founder lines were genotyped by PCR by using the following primers: forward 5′-TCTCTGCCCAGAGTCATCCT-3′, reverse 5′-ATGCTCCTGTCTGTGTGCAG-3′. B6.129X1-Gt(ROSA)26Sor^tm1Hjf^ (*R26-eyfp*) mice were purchased from The Jackson Laboratories. *Ltbr* ^*fl/fl*^ mice ([@bib48]) were described previously. C57BL/6N mice were obtained from Charles River (Sulzfeld, Germany) and *plt/plt* mice were obtained from the Institute of Laboratory Animal Sciences (University of Zurich, Switzerland). All animals were kept under conventional conditions in individually ventilated cages. Experiments were performed in accordance with Swiss federal and cantonal guidelines (Tierschutzgesetz) under the permission numbers SG11/05 and SG11/04 granted by the Veterinary Office of the Canton of St. Gallen.

Preparation of Stromal Cells {#sec4.2}
----------------------------

LNs were dissected into small pieces and transferred into a 24-well dish filled with RPMI 1640 medium containing 2% FCS, 20 mM HEPES (all from Lonza), 1 mg/ml Collagenase Type IV (Sigma), and 25 μg/ml DNaseI (Applichem). Dissociated LNs were incubated at 37°C for 30 min. After enzymatic digestion, cell suspensions were washed with PBS containing 0.5% FCS and 10 mM EDTA. To enrich the stromal cell fraction, hematopoietic cells were depleted by incubating the cell suspension with MACS anti-CD45 Microbeads and passing over a MACS LS column (Miltenyi).

Flow Cytometry and Cell Sorting {#sec4.3}
-------------------------------

Single-cell suspensions were incubated for 20 min at 4°C in PBS containing 1% FCS and 10 mM EDTA with the following fluorescently labeled antibodies: anti-CD45, anti-PDPN, anti-CD31, anti-LTβR, anti-VCAM-1, and anti-ICAM-1 (all from eBioscience), anti-CD3, anti-CD4, anti-CD8, anti-B220, anti-CD11c, anti-CD11b, anti-F4/80 (all from BD Biosciences). Cells were acquired with a FACS Canto (BD Biosciences) and analyzed by using FlowJo software (Treestar). Cell sorting was performed by using a FACS Aria cell sorter (BD Biosciences).

Quantitative Real-Time PCR {#sec4.4}
--------------------------

Total cellular RNA was extracted from homogenized tissues and sorted cells by using TRIZOL reagent (Invitrogen) following the manufacturers' protocol. cDNA was prepared by using cDNA archive kit (Applied Biosystems) and quantitative RT-PCR was performed by using the Light Cycler-FastStart DNA Master SYBR Green I kit (Roche Diagnostics) on a LightCycler machine (Roche Diagnostics). mRNA expression was measured by using the following primers: *Ccl19* forward CTGCCTCAGATTATCTGCCAT, reverse AGGTAGCGGAAGGCTTTCAC; *Ccl21* forward AAGGCAGTGATGGAGGGG, reverse CGGGGTAAGAACAGGATTG; *tata-box binding protein* (tbp) forward CCTTCACCAATGACTCCTATGAC, reverse CAAGTTTACAGCCAAGATTCAC; *Cxcl13* forward ACAGCAACGCTGCTTCTCC, reverse AATCACTCCAGAACACCTAC; *cre* forward ATGCTCCTGTCTGTGTGCAG, reverse GGAGGGCAGATCTCCTGTG; *Acta2* (QuantiTect Primer Assay QT00140119, QIAGEN); *cspg4* (QuantiTect Primer Assay QT00143220); C*nn1* (QuantiTect Primer Assay QT00105420); P*dgfra* (QuantiTect Primer Assay QT00140021); *Pdgfrb* (QuantiTect Primer Assay QT00113148).

Immunohistochemistry {#sec4.5}
--------------------

Lymph nodes were fixed overnight in freshly prepared 4% paraformaldehyde (Merck) at 4°C under agitation. Fixed LNs were embedded in 4% low melting agarose (Invitrogen) in PBS and sectioned with a vibratome (Leica VT-1200). We blocked 20--30 μm thick sections in PBS containing 10% FCS, 1 mg/ml anti-Fcγ receptor (BD Biosciences), and 0.1% Triton X-100 (Sigma). Sections were incubated overnight at 4°C with the following antibodies: anti-PDPN, anti-B220, anti-CD31, anti-CD4, anti-PDGFRβ, anti-LyveI, anti-E-Cadherin (all from eBioscience), anti-NG2 (Millipore), anti-SMA (Sigma), anti-EYFP (Clontech), anti-Calponin1, anti-CCL21, anti-CCL19, anti-Collagen I, anti-ERTR-7 (all from Abcam). Unconjugated antibodies were detected with the following secondary antibodies: Dylight649-conjugated anti-rat-IgG, Alexa488-conjugated anti-rabbit-IgG, Dylight549-conjugated anti-syrian hamster-IgG, and Dylight549-conjugated Streptavidin (all purchased from Jackson Immunotools). Microscopical analysis was performed by using a confocal microscope (Zeiss LSM-710) and images were processed with ZEN 2010 software (Carl Zeiss, Inc.) and Imaris (Bitplane).

Injection of Soluble Tracers {#sec4.6}
----------------------------

Mice were injected with 50 μg of 40 kDa FITC-Dextran (Molecular Probes) into the footpad and sacrificed two minutes after injection. Popliteal and inguinal LNs were excised and prepared for immunohistochemistry.

Optical Projection Tomography (OPT) {#sec4.7}
-----------------------------------

Mice received an intravenous injection of fluorescently labeled MECA-79 (15 μg) to label the HEV network. After 15 min, mice were sacrificed, LNs were carefully excised, and surrounding tissue was removed under a stereomicroscope. Sample preparation and OPT was performed as previously described ([@bib28]).

Two-Photon Intravital Microscopy {#sec4.8}
--------------------------------

Purified T cells were fluorescently labeled with 2.5 μM chloromethyl-benzoyl amino-tetramethylrhodamine (CMTMR) or CFSE for 15 min at 37°C. After washing, labeled T cells were injected intravenously into sex-matched mice, which were 24 hr later anesthetized and surgically prepared to expose the right popliteal lymph node. Two-photon microscopy (2PM) was performed as described ([@bib41]).

Virus Infections {#sec4.9}
----------------

Mice were infected intranasally with 5 × 10^4^ pfu of MHV A59 as previously described ([@bib7]). MHV titers were determined by standard plaque assay by using L929 cells. Analysis of MHV-specific CD8 T cell responses was performed by using PE-conjugated MHV S598/H-2K^b^ tetramers (Sanquin, Amsterdam, The Netherlands) as described ([@bib8]). For peptide-specific cytokine production, 10^6^ lymphocyte-enriched CNS cells were restimulated with S598 or M133 peptides and IFN-γ secretion was determined by flow cytometry as described ([@bib8]). LCMV infection and assessment of viral titers and antiviral T cell responses were done as described previously ([@bib9]).

Statistical Analysis {#sec4.10}
--------------------

2PM and OPT data were analyzed with Volocity (Perkin Elmer). All statistical analyses were performed with Prism 5.0 (Graphpad Software Inc.). Data were analyzed with the nonpaired Student's t test or as indicated in the figure legend. A p value of \< 0.05 was considered as significant.
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